AR094132A1 - Vacunas peptidicas para la prevencion de la fiebre aftosa - Google Patents

Vacunas peptidicas para la prevencion de la fiebre aftosa

Info

Publication number
AR094132A1
AR094132A1 ARP130101063A ARP130101063A AR094132A1 AR 094132 A1 AR094132 A1 AR 094132A1 AR P130101063 A ARP130101063 A AR P130101063A AR P130101063 A ARP130101063 A AR P130101063A AR 094132 A1 AR094132 A1 AR 094132A1
Authority
AR
Argentina
Prior art keywords
group
attached
prevention
terminal end
aftose
Prior art date
Application number
ARP130101063A
Other languages
English (en)
Inventor
Andreu Martinez David
Garcia De La Torre Beatriz
Blanco Lavilla Esther
Sobrino Castello Francisco
Monso Olivares Marta
Cubillos Zapata Carolina
Barcena Del Riego Juan
Original Assignee
Univ Pompeu Fabra
Consejo Superior De Investig Cientificas C S I C
Inst Nac De Investig Y Tecnologia Agraria Y Alimentaria Inia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pompeu Fabra, Consejo Superior De Investig Cientificas C S I C, Inst Nac De Investig Y Tecnologia Agraria Y Alimentaria Inia filed Critical Univ Pompeu Fabra
Publication of AR094132A1 publication Critical patent/AR094132A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/641—Branched, dendritic or hypercomb peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
    • A61K2039/645—Dendrimers; Multiple antigen peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Communicable Diseases (AREA)

Abstract

La solicitud se refiere a una construcción peptídica dendrimérica de fórmula (1) en la que: T es un epítopo T del VFA, unido al núcleo de lisina por su extremo N-terminal; B es un epítopo B del VFA, W es un grupo conectar, Z es Cys unida al grupo conector W a través de su átomo de azufre, o Lys unida al grupo conector W a través de su grupo e-amino; X no existe cuando B está unido al grupo a-carboxílico de Z por su extremo N-terminal, o es un grupo acilo cuando B está unido al grupo a-amino de Z por su extremo C-terminal. La solicitud también se refiere al uso de dichas construcciones como inmunógeno para la prevención de la fiebre aftosa en un animal.
ARP130101063A 2012-04-02 2013-04-03 Vacunas peptidicas para la prevencion de la fiebre aftosa AR094132A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12382135.7A EP2647390A1 (en) 2012-04-02 2012-04-02 Peptide vaccines for the prevention of foot-and-mouth disease

Publications (1)

Publication Number Publication Date
AR094132A1 true AR094132A1 (es) 2015-07-15

Family

ID=48095811

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP130101063A AR094132A1 (es) 2012-04-02 2013-04-03 Vacunas peptidicas para la prevencion de la fiebre aftosa

Country Status (4)

Country Link
EP (1) EP2647390A1 (es)
CN (1) CN104363925B (es)
AR (1) AR094132A1 (es)
WO (1) WO2013149974A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3909970A1 (en) * 2020-05-14 2021-11-17 Consejo Superior De Investigaciones Científicas Peptide vaccines for the prevention of foot-and-mouth disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US813998A (en) 1903-10-31 1906-02-27 Rail Joint Co Insulated rail-joint.
ES2319483B1 (es) 2006-08-02 2010-02-10 Instituto Nacional De Investigacion Y Tecnologia Agraria Y Alimentaria Construccion peptidica dendrimerica para la prevencion de la fiebre aftosa en animales.
CN102168088B (zh) * 2010-12-23 2012-12-26 中国农业科学院兰州兽医研究所 T细胞免疫原基因ti及其在口蹄疫蛋白亚单位疫苗和灭活疫苗中的应用

Also Published As

Publication number Publication date
EP2647390A1 (en) 2013-10-09
CN104363925A (zh) 2015-02-18
WO2013149974A1 (en) 2013-10-10
CN104363925B (zh) 2018-02-13

Similar Documents

Publication Publication Date Title
DOP2013000029A (es) Anticuerpos peptidicos beta amiloide anti-n3pglu y usos de los mismos
CL2017000830A1 (es) Formulación estable que comprende un azúcar no reductora, un anticuerpo anti-s4b7 y al menos un aminoácido libre; un método para preparar dicha formulación; uso de dicha formulación para tratar una enfermedad inflamatoria del intestino.
CY1116842T1 (el) Ειδικα εξανθρωπισμενα αντισωματα στην πρωτοϊνιδιακη μορφη του βητα-αμυλοειδους πεπτιδιου
BR112015023105A8 (pt) construto de imunógeno de peptídeo ab, seu uso, composição que o compreende, vacina de peptídeo para prevenção e imunoterapia de demência do tipo alzheimer e anticorpo.
PE20110023A1 (es) Composiciones inmunogenicas de antigenos de staphylococcus aureus
CO6382140A2 (es) Composiciones de vacuna que comprenden una proteina de enlace del factor h mutada
CY1117331T1 (el) Αντισωματα προσδεσης στην εξωκυτταρικη περιοχη 4 του ανθρωπινου csf1r και η χρηση αυτων
ES2585328T3 (es) Variantes no lipidadas de antígenos ORF2086 de Neisseria meningitidis
BR112015013183A2 (pt) proteínas de fusão para uso como aperfeiçoadores imunogênicos para indução de respostas de células t específicas para antígenos
CL2012003458A1 (es) Vector que comprende un polipeptido antigénico de campylobacter; composicion farmacéutica que comprende dicho vector; uso del vector para mejorar respuesta inmune del sujeto al polipéptido antigénico.
UA118332C2 (uk) Білок, що зв'язує антиген cd27l
CR20110091A (es) Anticuerpos neutralizantes de citomegalovirus humano y uso de los mismos
UA109633C2 (uk) Антитіло людини проти тканинного фактора
PE20142115A1 (es) Composiciones de neisseria meningitidis y metodos de las mismas
CO6210756A2 (es) La proteina linfopoyetina estromal timica canina y usos de la misma
PE20140986A1 (es) Proteinas de fusion y vacunas de combinacion que comprenden proteina e y pilina a de haemophilus influenzae
AR060565A1 (es) Vacuna para la gripe aviaria y metodos de uso
CY1120430T1 (el) Ανασυνδυασμενες cdv συνθεσεις και χρησεις αυτων
CL2008003197A1 (es) Anticuerpo que se une especificamente a la region n-terminal del peptido alfa-beta8-x; hibridoma y proceso de preparacion del anticuerpo; metodo para detectar la carga amiloide in vitro en un mamifero; kit, composicion terapeutica y de vacuna que comprenden al anticuerpo; uso del anticuerpo para tratar la enfermedad de alzheimer.
UY33665A (es) Derivado peptídico
PE20160878A1 (es) Polipeptidos ciclicos para el tratamiento de la insuficiencia cardiaca
IT1397734B1 (it) Uso di estratti naturali di tannini e non tannini atti a migliorare la fertilita' del suolo e determinare un effetto starter sulle colture, e fitocomplesso di tannini e di non tannini per tale uso.
EA201692279A1 (ru) Способ уменьшения иммуногенности белка и пептида
AR092897A1 (es) Composiciones inmunogenicas
MD20100029A (ro) Herpesvirus recombinant al crapului de koi (KHV) sau Cyprinid herpesvirus 3 (CyHV-3) si vaccin pentru prevenirea bolii cauzate de KHV/CyHV-3 la Cyprinus carpio carpio sau Cyprinus carpio koi

Legal Events

Date Code Title Description
FB Suspension of granting procedure